GSK

GlaxoSmithKline Pharmaceuticals Ltd, the Indian unit of UK's GSK plc, reported a 9.5% rise in profit, in line with analysts' estimates, as a sharp drop in input costs more than offset revenue decline

GlaxoSmithKline Pharmaceuticals on Friday said its net profit increased 3 per cent to Rs 193 crore in the second quarter ended September. The drug maker had reported a net profit from continuing operations at Rs 187 crore in the July-September period of the previous fiscal. However, revenue from operations declined to Rs 906 crore in the second quarter of the current fiscal compared to Rs 916 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing. "GSK India has delivered another quarter of strong performance in general medicines and specialty business, gaining market share. We hope to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth," GlaxoSmithKline Pharmaceuticals Managing Director Sridhar Venkatesh said. Vaccines business was impacted due to low vaccination rates as the overall market for the self-pay segment in which the company operates continues to decline, he ...

Brown, also 60, will join GSK in April and take up the job in May. She has extensive experience in the health and pharmaceutical industry.

Sanofi fell 13% on Thursday, taking its 2-day decline to 20%; GSK slid 6.9%

The companies point to the risk of new variants and waning immunity that could lead to an increase in demand for additional booster shots in some populations.

GlaxoSmithKline's IV drug for Covid-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most US cases, federal health regulators said

Sanofi-GSK's shot relies on a conventional protein-based approach, compared with the newer mRNA technology used in established Covid-19 vaccines from Pfizer-BioNTech and Moderna

Consumer protection regulator CCPA has passed an order against GlaxoSmithKline Consumer Healthcare Ltd directing it to discontinue advertisements of Sensodyne products in India for flouting norms.

The Dove soap owner said Monday it will announce a revamp of its structure later this month

Unilever confirms interest in GSK assets, says GSK consumer business would be 'strong strategic fit'; UK's Sunday Times says 50 billion-pound bid rejected in late 2021

This vaccine has been in development for 30 long years

The encouraging news on its "second-generation" vaccine gave CureVac's German-listed shares an 8% lift, as the stock gradually recovers from a slump in June

India part of 35,000 volunteer global efficacy trial

Investors have been waiting for details of the separation

Shares in GSK erased losses and traded more than 7% higher

GlaxoSmithKline has dismissed Moncef Slaoui as chairman of a company controlled by the British drugmaker after an internal investigation found he had sexually harassed an employee several years ago

Former U.S. President Donald Trump appointed Slaoui to lead his administration's effort to produce and distribute COVID-19 vaccines last year

Drugmaker GlaxoSmithKline said Wednesday it will work with a German biopharmaceutical company to develop new vaccines targeting emerging variants of COVID-19

The agreement includes transfer of manufacturing of the protein part of the malaria vaccine

The agreement includes transfer of manufacturing of the protein part of the vaccine